Actilyse 20mg

Actilyse 20mg is a medicine authorised by Swissmedic under authorisation number 48313. The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 September 1988 and the authorisation is valid without a time limit. ATC code B01AD02 places the medicine in the group Antithrombotic agents.

  • Dispensing category B
  • Authorisation number 48313
  • ATC B01AD02
  • Biotechnological medicines
Authorisation data
Authorisation number48313
NameActilyse 20mg
Full nameActilyse 20mg, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
Authorisation holderBoehringer Ingelheim (Schweiz) GmbH
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeB01AD02
First authorisation19 September 1988
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Actilyse 20mg, Pulver und Lösungsmittel zur Herstellung einer Injektions-/InfusionslösungB19 September 1988
2Actilyse 50mg, Pulver und Lösungsmittel zur Herstellung einer Injektions-/InfusionslösungB19 September 1988
3Actilyse 10mg, Pulver und Lösungsmittel zur Herstellung einer Injektions-/InfusionslösungB29 March 1994

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
271 x 20mgB01AD0206.05.0.B
191 x 50mgB01AD0206.05.0.B
351 x 10mgB01AD0206.05.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Actilyse 20mg authorised in Switzerland?

Yes. Actilyse 20mg is authorised by Swissmedic under authorisation number 48313, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Actilyse 20mg have?

Actilyse 20mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Actilyse 20mg?

The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com